ClinConnect ClinConnect Logo
Search / Trial NCT06248268

Neuropsychological Patterns of Suicide Ideators and Suicide Attempters

Launched by UNIVERSITY OF BERN · Jan 30, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Neuropsychological Patterns of Suicide Ideators and Suicide Attempters," is studying the mental and emotional differences between people who have thought about suicide, those who have attempted it, and those who have not experienced these thoughts or behaviors. The main goal is to understand how different psychological factors play a role in these experiences. Participants will undergo a one-time assessment at a hospital in Switzerland to help researchers learn more about these patterns.

To join the study, participants must be at least 18 years old and provide their consent. Individuals who have previously attempted suicide and are open to a specific therapy called ASSIP can be part of the "suicide attempters" group. There are also groups for those who have thoughts of suicide, those with no suicidal thoughts or actions, and healthy individuals. However, certain people, like those with severe cognitive issues or serious mental disorders, cannot participate. This study is currently recruiting, and it offers a chance to contribute to important research that could help improve support for individuals struggling with suicidal thoughts and behaviors.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects fulfilling the following inclusion criteria are eligible for the study:
  • Informed consent as documented by signature
  • Age ≥ 18 years
  • Additional inclusion criteria for the SUAT group:
  • At least one previous suicide attempt
  • Willingness to attend the ASSIP brief therapy
  • For the SUID, CLIN, and HLTH groups, no further inclusion criteria are formulated.
  • Exclusion Criteria:
  • The presence of any one of the following exclusion criteria will lead to exclusion of the subject:
  • Serious cognitive impairment
  • Any psychotic disorder
  • Any current medication, which substantially impairs the attention span, reaction, rate or any other relevant cognitive functions
  • Inability to follow the procedures of the study (e.g., insufficient mastery of the German language, previous enrolment into the current study)
  • Additional exclusion criterion for the SUID, CLIN and HLTH group:
  • • Previous suicidal behavior
  • Additional exclusion criteria for the CLIN and HLTH groups:
  • • Suicidal ideation

About University Of Bern

The University of Bern, a leading research institution in Switzerland, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university fosters an environment where scientific inquiry and clinical application intersect. Its commitment to ethical standards and patient safety ensures that all trials are conducted with the highest integrity, striving to contribute valuable insights to the global medical community. The University of Bern actively engages in diverse therapeutic areas, aiming to translate research findings into tangible health solutions.

Locations

Bern, , Switzerland

Patients applied

0 patients applied

Trial Officials

Anja C. Gysin-Maillart, Ph.D.

Principal Investigator

University of Bern, University Hospital of Psychiatry, Translational Research Center

Lara M. Aschenbrenner, M.Sc.

Study Chair

University of Bern, University Hospital of Psychiatry, Translational Research Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported